These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A review of inhaled technosphere insulin. Neumiller JJ; Campbell RK; Wood LD Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus. Ceglia L; Lau J; Pittas AG Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580 [TBL] [Abstract][Full Text] [Related]
7. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Rosenstock J; Zinman B; Murphy LJ; Clement SC; Moore P; Bowering CK; Hendler R; Lan SP; Cefalu WT Ann Intern Med; 2005 Oct; 143(8):549-58. PubMed ID: 16230721 [TBL] [Abstract][Full Text] [Related]
8. Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Rosenstock J; Cappelleri JC; Bolinder B; Gerber RA Diabetes Care; 2004 Jun; 27(6):1318-23. PubMed ID: 15161782 [TBL] [Abstract][Full Text] [Related]
9. Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes. Ellis SL; Gemperline KA; Garg SK Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S48-56. PubMed ID: 17563304 [TBL] [Abstract][Full Text] [Related]
10. Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes. Hollander PA MedGenMed; 2007 Mar; 9(1):45. PubMed ID: 17435648 [TBL] [Abstract][Full Text] [Related]
11. Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes. Hermansen K; Rönnemaa T; Petersen AH; Bellaire S; Adamson U Diabetes Care; 2004 Jan; 27(1):162-7. PubMed ID: 14693983 [TBL] [Abstract][Full Text] [Related]
12. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus. Mathieu C Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394 [TBL] [Abstract][Full Text] [Related]
13. Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus. Dunn C; Curran MP Drugs; 2006; 66(7):1013-32. PubMed ID: 16740022 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of inhaled insulin therapy for diabetes mellitus. Siddiqui NI Mymensingh Med J; 2007 Jul; 16(2):237-45. PubMed ID: 17703168 [TBL] [Abstract][Full Text] [Related]
15. Inhaled insulin in diabetes mellitus. Royle P; Waugh N; McAuley L; McIntyre L; Thomas S Cochrane Database Syst Rev; 2004; (3):CD003890. PubMed ID: 15266506 [TBL] [Abstract][Full Text] [Related]
16. Inhaled insulin in diabetes mellitus. Royle P; Waugh N; McAuley L; McIntyre L; Thomas S Cochrane Database Syst Rev; 2003; (3):CD003890. PubMed ID: 12917994 [TBL] [Abstract][Full Text] [Related]
17. Insulin glargine: a systematic review of a long-acting insulin analogue. Wang F; Carabino JM; Vergara CM Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485 [TBL] [Abstract][Full Text] [Related]
18. Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice. Heinemann L; Parkin CG J Diabetes Res; 2018; 2018():4568903. PubMed ID: 29707584 [TBL] [Abstract][Full Text] [Related]